Mark M Zalupski: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma

Rashmi Chugh, Thomas Wagner, Kent A. Griffith, Jeremy M.G. Taylor, Dafydd G. Thomas, Francis P. Worden, Kirsten M. Leu, Mark M. Zalupski, Laurence H. Baker

Journal:

Year:

2007

Language:

english

File:

PDF, 190 KB

english, 2007

2

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma

Sahai, Vaibhav, Catalano, Paul J., Zalupski, Mark M., Lubner, Sam Joseph, Menge, Mark R., Nimeiri, Halla Sayed, Munshi, Hidayatullah G., Benson, Al Bowen, O’Dwyer, Peter J.

Journal:

Year:

2018

Language:

english

File:

PDF, 352 KB

english, 2018

3

Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors

Basil F. El-Rayes, Dina Ibrahim, Anthony F. Shields, Patricia M. LoRusso, Mark M. Zalupski, Philip A. Philip

Journal:

Investigational New Drugs

Year:

2005

Language:

english

File:

PDF, 59 KB

english, 2005

4

Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma

Welling, Theodore H., Feng, Mary, Wan, Shanshan, Hwang, Sin Ye, Volk, Michael L., Lawrence, Theodore S., Zalupski, Mark M., Sonnenday, Christopher J.

Journal:

Liver Transplantation

Year:

2014

Language:

english

File:

PDF, 421 KB

english, 2014

5

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

O’Reilly, Eileen M., Lee, Jonathan W., Zalupski, Mark, Capanu, Marinela, Park, Jennifer, Golan, Talia, Tahover, Esther, Lowery, Maeve A., Chou, Joanne F., Sahai, Vaibhav, Brenner, Robin, Kindler, Hedy

Journal:

Journal of Clinical Oncology

Year:

2020

Language:

english

File:

PDF, 732 KB

english, 2020

6

Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma : A Southwest Oncology Group pilot trial

Cynthia Gail Leichman, Joth R. Jacobson, Manuel Modiano, John R. Daniels, Mark M. Zalupski, James H. Doroshow, William S. Fletcher, John S. Macdonald

Journal:

Year:

1999

Language:

english

File:

PDF, 81 KB

english, 1999

7

Multidrug resistance phenotype in high grade soft tissue sarcoma : Correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy

Rafael E. Jimenez, Mark M. Zalupski, John J. Frank, Wei Du, James R. Ryan, David R. Lucas

Journal:

Year:

1999

Language:

english

File:

PDF, 279 KB

english, 1999

8

Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas

Hiroshi Kunikane, Mark M. Zalupski, Cheppail Ramachandran, Mark A. KuKuruga, David Lucas, James R. Ryan, Awtar Krishan

Journal:

Cytometry Part A

Year:

1997

Language:

english

File:

PDF, 85 KB

english, 1997

9

A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma

Mark M. Zalupski, John F. Ensley, James Ryan, Suzanne Selvaggi, Laurence H. Baker, Sandra R. Wolman

Journal:

Year:

1990

Language:

english

File:

PDF, 1.23 MB

english, 1990

10

Cytogenetic findings-in 19 malignant bone tumors

Yavuz Y. Ozisik, Aurelia M. Meloni, Andrea Peier, Oguz Altungoz, Avery A. Sandberg, Suzanne S. Spanier, Mark M. Zalupski, Stanley P. L. Leong

Journal:

Year:

1994

Language:

english

File:

PDF, 835 KB

english, 1994

11

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

Philip A. Philip, Mark M. Zalupski, V. K. Vaitkevicius, Patricia Arlauskas, Ruth Chaplen, Lance K. Heilbrun, Volkan Adsay, Donald Weaver, Anthony F. Shields

Journal:

Year:

2001

Language:

english

File:

PDF, 101 KB

english, 2001

12

On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer

Cornelius J. McGinn, Theodore S. Lawrence, Mark M. Zalupski

Journal:

Year:

2002

Language:

english

File:

PDF, 107 KB

english, 2002

13

Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine : A Phase II trial

Anthony F. Shields, Mark M. Zalupski, John L. Marshall, Neal J. Meropol

Journal:

Year:

2004

Language:

english

File:

PDF, 85 KB

english, 2004

14

Adjuvant therapy of osteosarcoma—A Phase II trial : Southwest Oncology Group study 9139

Mark M. Zalupski, Cathryn Rankin, James R. Ryan, David R. Lucas, Jeffrey Muler, Keith S. Lanier, George Thomas Budd, J. Sybil Biermann, Frederick J. Meyers, Karen Antman

Journal:

Year:

2004

Language:

english

File:

PDF, 101 KB

english, 2004

15

Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site

Bryan J. Schneider, Basil El-Rayes, Jeffery H. Muler, Philip A. Philip, Gregory P. Kalemkerian, Kent A. Griffith, Mark M. Zalupski

Journal:

Year:

2007

Language:

english

File:

PDF, 92 KB

english, 2007

16

DNA content parameters of paraffin-embedded soft tissue sarcomas: Optimization of retrieval technique and comparison to fresh tissue

Mark M. Zalupski, Zosia Maciorowski, James R. Ryan, John F. Ensley, Mohamed E. Hussein, Alistair S. Sundareson, Laurence H. Baker

Journal:

Cytometry Part A

Year:

1993

Language:

english

File:

PDF, 647 KB

english, 1993

17

Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms

Mark M. Zalupski, James R. Ryan, John F. Ensley, Zosia Maciorowski, Haline Pietraszkiewicz, Mohamed E. Hussein, Mark Kukuruga, Alistair S. Sundareson, Laurence H. Baker

Journal:

Cytometry Part A

Year:

1993

Language:

english

File:

PDF, 911 KB

english, 1993

18

Systemic therapy for advanced gastrointestinal stromal tumors: Beyond imatinib

Edward J. Kim, Mark M. Zalupski

Journal:

Journal of Surgical Oncology

Year:

2011

Language:

english

File:

PDF, 88 KB

english, 2011

19

Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer

Bryan J. Schneider, Edgar Ben-Josef, Cornelius J. McGinn, Alfred E. Chang, Lisa M. Colletti, Daniel P. Normolle, Gwen F. Hejna, Theodore S. Lawrence, Mark M. Zalupski

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2005

Language:

english

File:

PDF, 116 KB

english, 2005

20

External-beam radiotherapy for localized extrahepatic cholangiocarcinoma

Merav A. Ben-David, Kent A. Griffith, Eyad Abu-Isa, Theodore S. Lawrence, James Knol, Mark Zalupski, Edgar Ben-Josef

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2006

Language:

english

File:

PDF, 170 KB

english, 2006

21

Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer

James D. Murphy, Saroja Adusumilli, Kent A. Griffith, Michael E. Ray, Mark M. Zalupski, Theodore S. Lawrence, Edgar Ben-Josef

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2007

Language:

english

File:

PDF, 193 KB

english, 2007

22

Radiotherapy for Pancreatic Neuroendocrine Tumors

Joseph N. Contessa, Kent A. Griffith, Elizabeth Wolff, William Ensminger, Mark Zalupski, Theodore S. Lawrence, Edgar Ben-Josef

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2009

Language:

english

File:

PDF, 251 KB

english, 2009

23

Gemcitabine-Based Combination Chemotherapy Followed by Radiation With Capecitabine as Adjuvant Therapy for Resected Pancreas Cancer

Sameer Desai, Edgar Ben-Josef, Kent A. Griffith, Diane Simeone, Joel K. Greenson, Isaac R. Francis, Janet Hampton, Lisa Colletti, Alfred E. Chang, Theodore S. Lawrence, Mark M. Zalupski

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2009

Language:

english

File:

PDF, 214 KB

english, 2009

24

Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic

Zvi Symon, Mary Davis, Cornelius J McGinn, Mark M Zalupski, Theodore S Lawrence

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2002

Language:

english

File:

PDF, 85 KB

english, 2002

25

Radiation therapy with once-weekly gemcitabine in pancreatic cancer: Current status of clinical trials

Cornelius J. McGinn, Mark M. Zalupski

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2003

Language:

english

File:

PDF, 242 KB

english, 2003

26

Adjuvant radiotherapy for adult soft tissue sarcoma: A fifteen year experience

Nitin Vaishampayan, Edgar Ben-Josef, Falah Shamsa, Paul Chuba, James Fontanesi, Mark Zalupski, James Ryan, Arthur Porter

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1996

Language:

english

File:

PDF, 131 KB

english, 1996

27

Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas

John B Ammori, Lisa M Colletti, Mark M Zalupski, Frederic E Eckhauser, Joel K Greenson, Justin Dimick, Theodore S Lawrence, Cornelius J McGinn

Journal:

Journal of Gastrointestinal Surgery

Year:

2003

Language:

english

File:

PDF, 224 KB

english, 2003

28

Phase I trial of Adozelesin using the treatment schedule of daily × 5 every 3 weeks

Brenda J. Foster, Patricia M. LoRusso, Elizabeth Poplin, Mark Zalupski, Manuel Valdivieso, Antoinette Wozniak, Lawrence Flaherty, Dorothy A. Kasunic, Robert H. Earhart, Laurence H. Baker

Journal:

Investigational New Drugs

Year:

1995-1996

Language:

english

File:

PDF, 525 KB

english, 1995-1996

29

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas

Mark M. Zalupski, Jacqueline Benedetti, Stanley P. Balcerzak, Laura F. Hutchins, Robert J. Belt, Alexander Hantel, John Wendall Goodwin

Journal:

Investigational New Drugs

Year:

1993

Language:

english

File:

PDF, 390 KB

english, 1993

30

Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer

Bassel F. El-Rayes, Mark M. Zalupski, Stephanie G. Manza, Barbara Rusin, Ann Marie Ferris, Ulka Vaishampayan, Lance K. Heilbrun, Raghu Venkatramanamoorthy, Anthony F. Shields, Philip A. Philip

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2008

Language:

english

File:

PDF, 304 KB

english, 2008

31

A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Steven J. Cohen, Mark M. Zalupski, Manuel R. Modiano, Paul Conkling, Yehuda Z. Patt, Peg Davis, Robert T. Dorr, Michelle L. Boytim, Evan M. Hersh

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2010

Language:

english

File:

PDF, 275 KB

english, 2010

32

A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas

Marisa E. Hill, Xiaobai Li, Sharon Kim, Angela Campbell, Kristy Culler, Mark Bloomston, Mark Zalupski, Gwen Hejna, Tanios Bekaii-Saab

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 266 KB

english, 2011

33

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma

Mark M. Zalupski, Philip A. Philip, Patricia LoRusso, Anthony F. Shields

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1997

Language:

english

File:

PDF, 101 KB

english, 1997

34

Phase II study of CI-958 in colorectal cancer

Anthony F. Shields, Philip A. Philip, Patricia M. LoRusso, Ann M. Ferris, Mark M. Zalupski

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1999

Language:

english

File:

PDF, 67 KB

english, 1999

35

A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer

Basil F. El-Rayes, Mark M. Zalupski, Anthony F. Shields, Ann Marie Ferris, Ulka Vaishampayan, Lance K. Heilbrun, Raghu Venkatramanamoorthy, Volkan Adsay, Philip A. Philip

Journal:

Investigational New Drugs

Year:

2005

Language:

english

File:

PDF, 716 KB

english, 2005

36

A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC)

Tanios S. Bekaii-Saab, Amir Mortazavi, Lee G. Hicks, Mark Zalupski, Robert J. Pelley, Kenneth K. Chan, Eric H. Kraut

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 206 KB

english, 2006

37

A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer

Elaina M. Gartner, Kent A. Griffith, Quintin Pan, George J. Brewer, Gwen F. Henja, Sofia D. Merajver, Mark M. Zalupski

Journal:

Investigational New Drugs

Year:

2009

Language:

english

File:

PDF, 136 KB

english, 2009

38

Gastrointestinal stromal tumors: Chemotherapy and imatinib

Jeffrey H. Muler, Laurence Baker, Mark M. Zalupski

Journal:

Current Oncology Reports

Year:

2002

Language:

english

File:

PDF, 2.23 MB

english, 2002

39

Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine

Aaron M. Allen, Mark M. Zalupski, John M. Robertson, Frederic E. Eckhauser, Diane Simone, Diane Brown, Gwen Hejna, Daniel Normolle, Theodore S. Lawrence, Cornelius J. McGinn

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2004

Language:

english

File:

PDF, 339 KB

english, 2004

40

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

Nazik HAMMAD, Lance K HEILBRUN, Philip A PHILIP, Anthony F SHIELDS, Mark M ZALUPSKI, Raghu VENKATRAMANAMOORTHY, Bassel F EL-RAYES

Journal:

Asia-Pacific Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 225 KB

english, 2010

41

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma

Mark M. Zalupski, Anthony F. Shields, Philip A. Philip, Michael Kraut, Patricia LoRusso, Lance K. Heilbrun, Vainutis Vaitkevicius

Journal:

Investigational New Drugs

Year:

1998

Language:

english

File:

PDF, 71 KB

english, 1998

42

Chronic Oral Administration of CI-994: A Phase I Study

Sucharu Prakash, Brenda J. Foster, Mark Meyer, Antoinette Wozniak, Lance K. Heilbrun, Lawrence Flaherty, Mark Zalupski, Louis Radulovic, Manuel Valdivieso, Patricia M. LoRusso

Journal:

Investigational New Drugs

Year:

2001

Language:

english

File:

PDF, 99 KB

english, 2001

43

Phase I Clinical Trial of 5-Fluoro-Pyrimidinone (5FP), an Oral Prodrug of 5-Fluorouracil (5FU)

Patricia M. LoRusso, Sucharu Prakash, Antoinette Wozniak, Lawrence Flaherty, Mark Zalupski, Anthony Shields, Howard Sands, Ralph Parchment, Bhaskara Jasti

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 97 KB

english, 2002

44

A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

Mark S. Talamonti, William Small, Mary F. Mulcahy, Jeffrey D. Wayne, Vikram Attaluri, Lisa M. Colletti, Mark M. Zalupski, John P. Hoffman, Gary M. Freedman, Timothy J. Kinsella, Philip A. Philip, Corn

Journal:

Annals of Surgical Oncology

Year:

2006

Language:

english

File:

PDF, 298 KB

english, 2006

45

Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy : A pooled analysis of 6 prospective trials

Todd M. Bauer, Bassel F. El-Rayes, Xiaobai Li, Nazik Hammad, Philip A. Philip, Anthony F. Shields, Mark M. Zalupski, Tanios Bekaii-Saab

Journal:

Year:

2012

Language:

english

File:

PDF, 327 KB

english, 2012

46

Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers

Laurel L. Northouse, Darlene W. Mood, Ann Schafenacker, Gregory Kalemkerian, Mark Zalupski, Patricia LoRusso, Daniel F. Hayes, Maha Hussain, John Ruckdeschel, A. Mark Fendrick, Peter C. Trask, David L

Journal:

Psycho-Oncology

Year:

2012

Language:

english

File:

PDF, 236 KB

english, 2012

47

Secondary acute myeloid leukemia as a result of chemotherapy for soft tissue sarcoma

Mary Varterasian, Mark Zalupski, Chatchada Karanes, Larisa Cherednikova, Sabbir Chaiwala

Journal:

Leukemia Research

Year:

1994

Language:

english

File:

PDF, 145 KB

english, 1994

48

Deletion 6q in three cases of mixed type liposarcoma in addition to t(12;16)(q13;p11)

Oguz Altungoz, Aurelia M. Meloni, Andrea Peier, Mark Zalupski, Suzanne Spanier, John S.J. Brooks, Avery A. Sandberg

Journal:

Cancer Genetics and Cytogenetics

Year:

1995

Language:

english

File:

PDF, 561 KB

english, 1995

49

Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma: A southwest oncology group study

Anwar N. Mohamed, Mark M. Zalupski, James R. Ryan, Fred Koppitch, Stanley Balcerzak, Raymond Kempf, Sandra R. Wolman

Journal:

Cancer Genetics and Cytogenetics

Year:

1997

Language:

english

File:

PDF, 1.17 MB

english, 1997

50

Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcoma

Scott M. Schuetze, Lili Zhao, Rashmi Chugh, Dafydd G. Thomas, David R. Lucas, Gino Metko, Mark M. Zalupski, Laurence H. Baker

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 275 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски